PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-12-11

Date Title Company
11-Dec-2020 Peptide Cancer Vaccine Market Future Trends Plan, Industry Growth Structure, Features, End Users, Business Opportunities, Worldwide Forecast To 2026 CDN Newswire
11-Dec-2020 Polyphor receives an additional USD 2.3 million award from CARB-X to support ongoing development of a new class of antibiotics targeting multi-drug resistant Gram-negative pathogens Polyphor AG
11-Dec-2020 Thyroid Deficiency Treatment Market Revenue to Decline During Coronavirus Disruption, Stakeholders to Realign Their Growth Strategies MARKITWIRED
11-Dec-2020 Prognostic Biomarkers Market Forecast Revised in a New FMI Report as COVID-19 Projected to Hold a Massive Impact on Sales in 2027 MARKITWIRED
11-Dec-2020 FMI’s Detailed Report on Netupitant-Palonosetron FDC Market Offers Projections of Potential Impact of Corona Virus Outbreak MARKITWIRED
11-Dec-2020 Global Anaesthesia Machines Market on a Steady Growth Trail; FMI Provides Projections in Light of COVID-19 Pandemic in its New Revised Report MARKITWIRED
11-Dec-2020 Orthobiologics Market Sales to Flatten Due to COVID-19 Pandemic; Key Market Players to Redesign Developmental Strategies MARKITWIRED
11-Dec-2020 Medartis appoints Dirk Kirsten as Chief Financial Officer and EMB member Medartis Holding AG
11-Dec-2020 COVID-19 Impact on Companion Diagnostics Market: Increasing Demand For Next-generation Sequencing MarketsandMarkets
11-Dec-2020 COVID-19 to Have Significant Effect on Worldwide Adoption of Muscle Relaxant Drugs Market in 2020 MARKITWIRED
11-Dec-2020 FMI Revises Regenerative Artificial Skin Market Forecast, as COVID-19 Pandemic Continues to Expand Quickly MARKITWIRED
11-Dec-2020 Fertility Tracking Apps Market Revenue to Decline During Coronavirus Disruption, Stakeholders to Realign Their Growth Strategies MARKITWIRED
11-Dec-2020 Cerebral Palsy Market to Face a Significant Slowdown in 2020, as COVID-19 Sets a Negative Tone for Investors MARKITWIRED
11-Dec-2020 Protagonist Therapeutics, Inc. Announces Pricing of $100 Million Public Offering of Common Stock Protagonist Therapeutics, Inc.
11-Dec-2020 Protagonist Therapeutics, Inc. Announces Pricing of $100 Million Public Offering of Common Stock Protagonist Therapeutics, Inc.